Use of Paclitaxel Coated Drug Eluting Technology to Improve Central Vein Patency for Haemodialysis Access Circuits: Any Benefit?

导出 LinkOut

翻译打印收藏纠错

作者： Tze Tec,Chong ^[1] ; Hao Yun,Yap ^[1] ; Chieh Suai,Tan ^[2] ; Qingwei Shaun,Lee ^[1] ; Sze Ling,Chan ^[3] ; Ian Jun Yan,Wee ^[4] ; Tjun Yip,Tang ^[1]

作者单位： Department of Vascular Surgery, Singapore General Hospital, Singapore. ^[1] Department of Interventional Nephrology, Singapore General Hospital, Singapore. ^[2] Health Services Research Center, SingHealth, Singapore. ^[3] Yong Loo Lin School of Medicine, National University of Singapore, Singapore. ^[4]

关键词 Balloon angioplasty Central venous stenosis Hemodialysis Paclitaxel Vascular patency

DOI 10.5758/vsi.2020.36.1.21

PMID 32292765

发布时间 2022-04-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Vascular specialist international

2020年36卷1期

21-27页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Use of Paclitaxel Coated Drug Eluting Technology to Improve Central Vein Patency for Haemodialysis Access Circuits: Any Benefit?

Vascular specialist international

相似文献

Vascular specialist international

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Use of Paclitaxel Coated Drug Eluting Technology to Improve Central Vein Patency for Haemodialysis Access Circuits: Any Benefit?

Vascular specialist international

相似文献

Vascular specialist international

相关期刊

检索历史清除